Treatment with 17-DMAG effectively abrogated the profibrotic effects of TGF-β in cultured dermal fibroblasts and prevented the development of experimental dermal fibrosis in three different murine models of SSc [26]. This evidence concerns the gene TGFB1 and systemic sclerosis.